This contract expires in 311 days (Feb 22, 2027).
FIRM FIXED PRICENO SET ASIDE USED.
BIOSKRYB GENOMICS, INC. - SINGLE CELL WHOLE GENOME SEQUENCING IN PERIPHERAL BLOOD OF PATIENTS WITH VEXAS SYNDROME
PIID: 75N98026P00014Solicitation ID: 75N92026Q00032
Signed Date: Feb 19, 2026Effective Date: Feb 23, 2026End Date: Closes in 311 days
Key Details
Description
SINGLE CELL WHOLE GENOME SEQUENCING IN PERIPHERAL BLOOD OF PATIENTS WITH VEXAS SYNDROME
Contractor Information
Similar Awards
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ALLUCENT GOVERNMENT SERVICES (US) LLC
$370.1M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
ICON GOVERNMENT AND PUBLIC HEALTH SOLUTIONS, INC.
$330.2M
CLINICAL SERVICES NETWORK- CLINICAL TRIAL PLANNING AND EXECUTION
TECHNICAL RESOURCES INTERNATIONAL, INC.
$317.1M
ANTIBIOTIC FOR TREATMENT OF A BIOTHREAT INDICATION
PARATEK PHARMACEUTICALS, INC
$265.3M
ASPR-18-04963 -- FUNDING FOR BALOXAVIR MARBOXIL ACTIVITIES FOR BASE PERIOD TASK UNDER THE GENENTECH OTA
GENENTECH INC
$243.7M
Stay Updated
Get notified about new opportunities matching your interests.